CAS 874902-19-9 appears in our catalog under these names: LY2183240, LY2183240/ 98.17% (existing batch purity), 5-([1,1'-Biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide, 99%, 99%, LY2183240, 98.04%. Offered by: TRC, TargetMol, GLPBio, Chemat, MedChemExpress. Available pack sizes: 250mg, 10mg, 25mg, 50mg, 100mg, 200mg, 1g, 100 mg.
LY-2183240 is a member of the class of tetrazoles that is 1H-tetrazole substituted by N,N-dimethylcarbonyl and [biphenyl]-4-ylmethyl groups at positions 1 and 5, respectively. It was developed by Eli Lilly as a potent inhibitor of anandamide re-uptake and fatty acid amide hydrolase, the enzyme responsible for degrading anandamide. It has a role as an anxiolytic drug, an analgesic and an EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor. It is a tertiary carboxamide, a member of biphenyls and a member of tetrazoles.
Source: ChEBI
| Molecular formula | C17H17N5O |
|---|---|
| Molecular weight | 307.35 g/mol |
| IUPAC name | N,N-dimethyl-5-[(4-phenylphenyl)methyl]tetrazole-1-carboxamide |
| InChIKey | GZNIYOXWFCDBBJ-UHFFFAOYSA-N |
| SMILES | CN(C)C(=O)N1C(=NN=N1)CC2=CC=C(C=C2)C3=CC=CC=C3 |
Computed by PubChem (NCBI)